Antigenics Inc.
Antigenics Announces Expansion of Investigator-Sponsored Study for Glioma
Published in Healthcare Mergers, Acquisitions and Ventures Week, July 11th, 2009
The Phase 2 trial is designed to recruit approximately 30 patients diagnosed with first recurrence of high-grade glioma. Patients undergo surgery to remove their tumors, which are then used to manufacture their patient-specific vaccines. The trial is designed to evaluate overall survival, time to progression and immune response.
"We are encouraged by the preliminary results generated from...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Mergers, Acquisitions and Ventures Week
More Articles from Healthcare Mergers, Acquisitions and Ventures Week
- 1-800-GOT-JUNK?
1-800-GOT-JUNK? Partners with Critical Concepts, Inc. to Take on the Foreclosure Market the Right Way - 19 Recordings LLC/RCA Records
19 Recordings/RCA Records Team Up to Release 'American Idol Season 8' Compilation To Be Sold Exclusively at Walmart - 3M
3M Files Patent Infringement Lawsuit Against Library Systems Manufacturer - 4Dr Inc.
4Dr Offers Webinars for Physicians To Help Select EHR Systems With Stimulus Bill Funds - 7-Eleven
Caught in the Act! - ABI Research
Worldwide Mobile Services Revenue to Grow at Least 1.2% Annually Through 2014, Says ABI Research - More from this issue of Healthcare Mergers, Acquisitions and Ventures Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
